Chana S Wasserman, MD | |
77 Mass Ave, Medical E23-395, Cambridge, MA 02139-4301 | |
(617) 253-0556 | |
Not Available |
Full Name | Chana S Wasserman |
---|---|
Gender | Female |
Speciality | Obstetrics/gynecology |
Experience | 31 Years |
Location | 77 Mass Ave, Cambridge, Massachusetts |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1336112291 | NPI | - | NPPES |
J24463 | Other | MA | BLUE CROSS |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207VG0400X | Obstetrics & Gynecology - Gynecology | 154463 (Massachusetts) | Secondary |
207VX0000X | Obstetrics & Gynecology - Obstetrics | 154463 (Massachusetts) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Massachusetts Institute Of Technology | 5597658666 | 51 |
News Archive
ImmunoCellular Therapeutics, Ltd. (OTCBB: IMUC), a clinical-stage biotechnology company that is developing immune based therapies for the treatment of brain and other cancers, announced today that it has entered into a research and license option agreement regarding its ICT-69 antibody with Roche Group (SWX: ROG.VX; RO.S, OTCQX: RHHBY), one of the world's leading research-focused healthcare groups in the fields of pharmaceuticals and diagnostics.
South African President Jacob Zuma in a speech on Thursday to mark World AIDS Day introduced a new five-year National Strategic Plan on HIV, sexually transmitted infections (STIs) and tuberculosis (TB), which "calls for stepped-up prevention efforts to halve new infections of HIV and tuberculosis by 2016 and to put 80 percent of eligible patients on antiretroviral drugs to fight AIDS," Agence France-Presse reports.
While this winter's warmer-than-average temperatures were a nice contrast for people who suffered through to last year's many winter storms, many may now pay for the balmy temperatures with an earlier and longer spring allergy season. For some, symptoms such as runny nose, nasal congestion, sneezing, itchy eyes, ears and throat, wheezing and shortness of breath have already begun and may last into early summer.
ImmunoCellular Therapeutics, Ltd. a biotechnology company focused on the development of novel immune-based cancer therapies, today announced that it will be presenting results from its clinical trial of ICT-107 at the 46th Annual Meeting of the American Society of Clinical Oncology (ASCO) being held June 4-8 in Chicago.
Nearly ten percent of all cases of depression are so severe that the patients do not respond to any established treatment method. Targeted stimulation of areas in the brain using a type of "brain pacemaker" has recently raised hopes: According to initial studies, half of patients with the most severe depression treated in this manner see a significant improvement in mood.
› Verified 6 days ago
Entity Name | Massachusetts Institute Of Technology |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1346308723 PECOS PAC ID: 5597658666 Enrollment ID: O20040203000789 |
News Archive
ImmunoCellular Therapeutics, Ltd. (OTCBB: IMUC), a clinical-stage biotechnology company that is developing immune based therapies for the treatment of brain and other cancers, announced today that it has entered into a research and license option agreement regarding its ICT-69 antibody with Roche Group (SWX: ROG.VX; RO.S, OTCQX: RHHBY), one of the world's leading research-focused healthcare groups in the fields of pharmaceuticals and diagnostics.
South African President Jacob Zuma in a speech on Thursday to mark World AIDS Day introduced a new five-year National Strategic Plan on HIV, sexually transmitted infections (STIs) and tuberculosis (TB), which "calls for stepped-up prevention efforts to halve new infections of HIV and tuberculosis by 2016 and to put 80 percent of eligible patients on antiretroviral drugs to fight AIDS," Agence France-Presse reports.
While this winter's warmer-than-average temperatures were a nice contrast for people who suffered through to last year's many winter storms, many may now pay for the balmy temperatures with an earlier and longer spring allergy season. For some, symptoms such as runny nose, nasal congestion, sneezing, itchy eyes, ears and throat, wheezing and shortness of breath have already begun and may last into early summer.
ImmunoCellular Therapeutics, Ltd. a biotechnology company focused on the development of novel immune-based cancer therapies, today announced that it will be presenting results from its clinical trial of ICT-107 at the 46th Annual Meeting of the American Society of Clinical Oncology (ASCO) being held June 4-8 in Chicago.
Nearly ten percent of all cases of depression are so severe that the patients do not respond to any established treatment method. Targeted stimulation of areas in the brain using a type of "brain pacemaker" has recently raised hopes: According to initial studies, half of patients with the most severe depression treated in this manner see a significant improvement in mood.
› Verified 6 days ago
Entity Name | Mt Auburn Professional Services |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1992750996 PECOS PAC ID: 6103725031 Enrollment ID: O20040527001374 |
News Archive
ImmunoCellular Therapeutics, Ltd. (OTCBB: IMUC), a clinical-stage biotechnology company that is developing immune based therapies for the treatment of brain and other cancers, announced today that it has entered into a research and license option agreement regarding its ICT-69 antibody with Roche Group (SWX: ROG.VX; RO.S, OTCQX: RHHBY), one of the world's leading research-focused healthcare groups in the fields of pharmaceuticals and diagnostics.
South African President Jacob Zuma in a speech on Thursday to mark World AIDS Day introduced a new five-year National Strategic Plan on HIV, sexually transmitted infections (STIs) and tuberculosis (TB), which "calls for stepped-up prevention efforts to halve new infections of HIV and tuberculosis by 2016 and to put 80 percent of eligible patients on antiretroviral drugs to fight AIDS," Agence France-Presse reports.
While this winter's warmer-than-average temperatures were a nice contrast for people who suffered through to last year's many winter storms, many may now pay for the balmy temperatures with an earlier and longer spring allergy season. For some, symptoms such as runny nose, nasal congestion, sneezing, itchy eyes, ears and throat, wheezing and shortness of breath have already begun and may last into early summer.
ImmunoCellular Therapeutics, Ltd. a biotechnology company focused on the development of novel immune-based cancer therapies, today announced that it will be presenting results from its clinical trial of ICT-107 at the 46th Annual Meeting of the American Society of Clinical Oncology (ASCO) being held June 4-8 in Chicago.
Nearly ten percent of all cases of depression are so severe that the patients do not respond to any established treatment method. Targeted stimulation of areas in the brain using a type of "brain pacemaker" has recently raised hopes: According to initial studies, half of patients with the most severe depression treated in this manner see a significant improvement in mood.
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Chana S Wasserman, MD Po Box 425789, Medical E23-395, Cambridge, MA 02142-0015 Ph: (617) 253-0556 | Chana S Wasserman, MD 77 Mass Ave, Medical E23-395, Cambridge, MA 02139-4301 Ph: (617) 253-0556 |
News Archive
ImmunoCellular Therapeutics, Ltd. (OTCBB: IMUC), a clinical-stage biotechnology company that is developing immune based therapies for the treatment of brain and other cancers, announced today that it has entered into a research and license option agreement regarding its ICT-69 antibody with Roche Group (SWX: ROG.VX; RO.S, OTCQX: RHHBY), one of the world's leading research-focused healthcare groups in the fields of pharmaceuticals and diagnostics.
South African President Jacob Zuma in a speech on Thursday to mark World AIDS Day introduced a new five-year National Strategic Plan on HIV, sexually transmitted infections (STIs) and tuberculosis (TB), which "calls for stepped-up prevention efforts to halve new infections of HIV and tuberculosis by 2016 and to put 80 percent of eligible patients on antiretroviral drugs to fight AIDS," Agence France-Presse reports.
While this winter's warmer-than-average temperatures were a nice contrast for people who suffered through to last year's many winter storms, many may now pay for the balmy temperatures with an earlier and longer spring allergy season. For some, symptoms such as runny nose, nasal congestion, sneezing, itchy eyes, ears and throat, wheezing and shortness of breath have already begun and may last into early summer.
ImmunoCellular Therapeutics, Ltd. a biotechnology company focused on the development of novel immune-based cancer therapies, today announced that it will be presenting results from its clinical trial of ICT-107 at the 46th Annual Meeting of the American Society of Clinical Oncology (ASCO) being held June 4-8 in Chicago.
Nearly ten percent of all cases of depression are so severe that the patients do not respond to any established treatment method. Targeted stimulation of areas in the brain using a type of "brain pacemaker" has recently raised hopes: According to initial studies, half of patients with the most severe depression treated in this manner see a significant improvement in mood.
› Verified 6 days ago
Kathleen Forest Harney, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1493 Cambridge St, Cambridge, MA 02139 Phone: 617-665-1600 | |
Dr. Arielle Caplin, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1493 Cambridge St, Cambridge, MA 02139 Phone: 617-665-1000 | |
Latoya Shari Jackson, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1493 Cambridge St, Cambridge, MA 02139 Phone: 617-498-1660 | |
Dr. Eman Elkadry, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 725 Concord Ave, Ste 3300, Cambridge, MA 02138 Phone: 617-354-5452 Fax: 617-497-7503 | |
Alexander Bruscke, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 725 Concord Ave Ste 3500, Cambridge, MA 02138 Phone: 617-354-5452 | |
Arthur G Spector, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1493 Cambridge St, Cambridge, MA 02139 Phone: 617-665-2800 | |
Dr. Jessica Leigh Verosko, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1493 Cambridge St, Cha - Ob/gyn - Cambridge Campus, Cambridge, MA 02139 Phone: 617-498-1660 |